S. 4550: Maternal Health Pandemic Response Act

The Maternal Health Pandemic Response Act is a legislative proposal aimed at improving the health outcomes of pregnant individuals and newborns, especially during public health emergencies. Here are the main components of what the bill would accomplish:

Funding for Research and Surveillance

- The bill authorizes funding for various programs to enhance data collection and research on maternal health during public health emergencies, including: - **$100 million** for the Surveillance for Emerging Threats to Mothers and Babies program to support efforts in providing timely health guidance to families and healthcare providers. - **$30 million** for the Enhancing Reviews and Surveillance to Eliminate Maternal Mortality (ERASE MM) program to provide technical assistance and support partnerships with maternal mortality review committees. - **$45 million** for the Pregnancy Risk Assessment Monitoring System (PRAMS) to supplement surveys that focus on public health emergencies and improve outreach to underrepresented communities. - **$15 million** for the National Institute of Child Health and Human Development to research interventions to mitigate the impacts of infectious diseases on maternal and infant health.

Public Health Emergency Data Collection

- The bill mandates the Centers for Disease Control and Prevention (CDC) to publicly release data related to maternal health, specifically during public health emergencies. This includes data on: - Diagnostic testing and health outcomes for pregnant individuals affected by infectious diseases. - Maternal and infant health outcomes for individuals who tested positive for these diseases.

Public Awareness Campaigns

- The CDC is tasked with conducting public health education campaigns to ensure that pregnant individuals and their health care providers have accurate information about maternal and infant health risks during public health emergencies. Special attention will be given to reaching underserved communities.

Task Force on Maternal Care

- A task force will be established to develop recommendations for safe, respectful, and empowering maternity care during public health emergencies. This task force will focus on: - Creating guidelines that ensure equitable treatment based on race and ethnicity. - Addressing barriers to accessing care, including telehealth options, mental health supports, and training for healthcare providers. - Ensuring that the care provided is culturally and linguistically appropriate.

Recommendations for Maternity Care Improvements

- The task force will create recommendations on various critical areas, such as respectful maternity care, the use of telehealth, mental health support, and addressing the needs of marginalized groups.

Data Privacy and Security

- Provisions are included to ensure privacy protections for individuals’ health information in accordance with federal regulations.

Collaboration with Tribes and Communities

- The bill emphasizes the importance of consulting with Native American and Alaska Native groups to address their specific health outcomes and needs.

Definitions

- The bill includes specific definitions for terms related to maternal health, such as "maternal mortality", "severe maternal morbidity", and "respectful maternity care", aiming to provide clarity in the legislation.

Funding Allocation

- Overall, the bill outlines a total of **$290 million** to be allocated across various programs dedicated to improving maternal health during public health emergencies.

Relevant Companies

• AMGN (Amgen Inc.) - Potentially impacted as a leading biotechnology company that develops therapies for maternal health conditions
• NVS (Novartis AG) - A pharmaceutical company that may need to adapt their maternal health medications in response to updated guidelines.
• PFE (Pfizer Inc.) - As a major pharmaceutical company, Pfizer might be involved in the production of vaccines and treatments relevant to maternal health.